UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease

Allergy (Copenhagen), 2015-11, Vol.70 (11), p.1393-1405

2015

Volltextzugriff (PDF)

Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children

Allergy (Copenhagen), 2012-02, Vol.67 (2), p.242-247

2012

Volltextzugriff (PDF)

Basophil allergen threshold sensitivity and component-resolved diagnostics improve hazelnut allergy diagnosis

Clinical and experimental allergy, 2015-09, Vol.45 (9), p.1412-1418

2015

Volltextzugriff (PDF)

Oral peanut challenge identifies an allergy but the peanut allergen threshold sensitivity is not reproducible

PloS one, 2013-01, Vol.8 (1), p.e53465-e53465

2013

Volltextzugriff (PDF)

Individually dosed omalizumab: an effective treatment for severe peanut allergy

Clinical and experimental allergy, 2017-04, Vol.47 (4), p.540-550

2017

Volltextzugriff (PDF)

EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance

Allergy (Copenhagen), 2024-02, Vol.79 (2), p.290-293

2024

Volltextzugriff (PDF)

After 6 years with Xolair; a 3-year withdrawal follow-up

Allergy (Copenhagen), 2010, Vol.65 (1), p.56-60

2010

Volltextzugriff (PDF)

size of the disease relevant IgE antibody fraction in relation to 'total-IgE' predicts the efficacy of anti-IgE (Xolair®) treatment

Allergy (Copenhagen), 2009-10, Vol.64 (10), p.1472-1477

2009

Volltextzugriff (PDF)

CD‐sens and clinical changes during withdrawal of Xolair after 6 years of treatment

Allergy, 2007-10, Vol.62 (10), p.1175-1181

2007

Volltextzugriff (PDF)

Anaphylaxis to Patent Blue V. I. Clinical aspects

Allergy (Copenhagen), 2010-01, Vol.65 (1), p.117-123

2010

Volltextzugriff (PDF)

Simultaneous exposure of several allergens has an additive effect on multisensitized basophils

Allergy, 2006-11, Vol.61 (11), p.1366-1368

2006

Volltextzugriff (PDF)

Peanut oral immunotherapy during omalizumab protection; a clinical trial on severely peanut allergic adolescents

ALLERGY, 2017, Vol.72, p.65

2017

Volltextzugriff (PDF)

Passive IgE‐sensitization by blood transfusion

Allergy (Copenhagen), 2005-09, Vol.60 (9), p.1192-1199

2005

Volltextzugriff (PDF)

Basophil allergen threshold sensitivity, CD-sens, is a measure of allergen sensitivity in asthma

Clinical and experimental allergy, 2011-08, Vol.41 (8), p.1091-1097

2011

Volltextzugriff (PDF)

Basophil allergen threshold sensitivity: a useful approach to anti‐IgE treatment efficacy evaluation

Allergy (Copenhagen), 2006-03, Vol.61 (3), p.298-302

2006

Volltextzugriff (PDF)

CD-sens: a biological measure of immunological changes stimulated by ASIT

Allergy (Copenhagen), 2009-05, Vol.64 (5), p.811-814

2009

Volltextzugriff (PDF)

Intravenous fluorescein as a cause of immunoglobulin E‐mediated anaphylactic shock

Acta anaesthesiologica Scandinavica, 2012-09, Vol.56 (8), p.1066-1068

2012

Volltextzugriff (PDF)

Pholcodine stimulates a dramatic increase of IgE in IgE‐sensitized individuals. A pilot study

Allergy (Copenhagen), 2006-01, Vol.61 (1), p.49-55

2006

Volltextzugriff (PDF)

CD-Sens Can Be a Reliable and Easy-to-Use Complement in the Diagnosis of Allergic Rhinitis

International archives of allergy and immunology, 2013-01, Vol.161 (1), p.87-90

2013

Volltextzugriff (PDF)

IgG4 antibodies and peanut challenge outcome in children IgE-sensitized to peanut

Pediatric allergy and immunology, 2015-06, Vol.26 (4), p.386-389

2015

Volltextzugriff (PDF)

Combining Analyses of Basophil Allergen Threshold Sensitivity, CD-sens, and IgE Antibodies to Hydrolyzed Wheat, ω-5 Gliadin and Timothy Grass Enhances the Prediction of Wheat Challenge Outcome

International archives of allergy and immunology, 2013-01, Vol.162 (1), p.50-57

2013

Volltextzugriff (PDF)

IgG 4 antibodies and peanut challenge outcome in children IgE‐sensitized to peanut

Pediatric allergy and immunology, 2015, Vol.26 (4), p.386-389

2015

Volltextzugriff (PDF)

Anaphylaxis to atracurium - a non-QAI-dependent reaction?

Acta anaesthesiologica Scandinavica, 2012-02, Vol.56 (2), p.262-263

2012

Volltextzugriff (PDF)

Pholcodine caused anaphylaxis in Sweden 30 years ago

Allergy, 2009-05, Vol.64 (5), p.820-821

2009

Volltextzugriff (PDF)

Of cats and mites: withdrawal of Xolair after prolonged use

Allergy (Copenhagen), 2010-04, Vol.65 (4), p.529-529

Panasoff, J

2010

Volltextzugriff (PDF)

1 – 25 von 268

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(248)
Mit Volltextzugriff
(230)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(175)
Life Sciences & Biomedicine
(165)
Humans
(104)
Medicin Och Hälsovetenskap
(83)
Immunology
(58)
Female
(56)
Male
(56)
Allergy
(46)
Biological And Medical Sciences
(42)
Middle Aged
(36)
Adult
(35)
Medical Sciences
(34)
Aged
(32)
Ecology
(28)
Allergies
(27)
Fundamental And Applied Biological Sciences. Psychology
(26)
Environmental Sciences & Ecology
(24)
Allergens - Immunology
(23)
Otorhinolaryngology
(21)
Adolescent
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease

Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children

Basophil allergen threshold sensitivity and component-resolved diagnostics improve hazelnut allergy diagnosis

Oral peanut challenge identifies an allergy but the peanut allergen threshold sensitivity is not reproducible

Individually dosed omalizumab: an effective treatment for severe peanut allergy

EAACI task force report: A consensus protocol for the basophil activation test for collaboration and external quality assurance

After 6 years with Xolair; a 3-year withdrawal follow-up

size of the disease relevant IgE antibody fraction in relation to 'total-IgE' predicts the efficacy of anti-IgE (Xolair®) treatment

CD‐sens and clinical changes during withdrawal of Xolair after 6 years of treatment

Anaphylaxis to Patent Blue V. I. Clinical aspects

Simultaneous exposure of several allergens has an additive effect on multisensitized basophils

Peanut oral immunotherapy during omalizumab protection; a clinical trial on severely peanut allergic adolescents

Passive IgE‐sensitization by blood transfusion

Basophil allergen threshold sensitivity, CD-sens, is a measure of allergen sensitivity in asthma

Basophil allergen threshold sensitivity: a useful approach to anti‐IgE treatment efficacy evaluation

CD-sens: a biological measure of immunological changes stimulated by ASIT

Intravenous fluorescein as a cause of immunoglobulin E‐mediated anaphylactic shock

Pholcodine stimulates a dramatic increase of IgE in IgE‐sensitized individuals. A pilot study

CD-Sens Can Be a Reliable and Easy-to-Use Complement in the Diagnosis of Allergic Rhinitis

IgG4 antibodies and peanut challenge outcome in children IgE-sensitized to peanut

Combining Analyses of Basophil Allergen Threshold Sensitivity, CD-sens, and IgE Antibodies to Hydrolyzed Wheat, ω-5 Gliadin and Timothy Grass Enhances the Prediction of Wheat Challenge Outcome

IgG 4 antibodies and peanut challenge outcome in children IgE‐sensitized to peanut

Anaphylaxis to atracurium - a non-QAI-dependent reaction?

Pholcodine caused anaphylaxis in Sweden 30 years ago

Of cats and mites: withdrawal of Xolair after prolonged use

Suchergebnisse filtern